Adrienne O. van Nieuwenhuizen
Observed names: A van Nieuwenhuizen, A. van Nieuwenhuizen, Adrienne O Van Nieuwenhuizen, Adrienne O van Nieuwenhuizen, Adrienne van Nieuwenhuizen, Van Nieuwenhuizen, Adrienne
Institution: University of California, San Francisco
Observed institutions: AstraZeneca (United Kingdom), Novartis (Switzerland), Merck & Co., Inc., Rahway, NJ, USA (United States), San Francisco VA Medical Center, United States Food and Drug Administration, National Institute on Drug Abuse, Boehringer Ingelheim (Germany), Harvard University, Janssen (Belgium), Eli Lilly (United States), University of California, San Francisco, Pfizer (United States), King's College London, GlaxoSmithKline (United Kingdom), Sunovion (United Kingdom), University of Cambridge, Sanofi (France), Abbott (United Kingdom), National Center for Complementary and Integrative Health, United BioSource Corporation (United Kingdom), Massachusetts General Hospital, Bristol-Myers Squibb (United States), Jazz Pharmaceuticals (United States), Nutrition 21 (United States), Psychogenics (United States), Alkermes (United States), Sunovion (United States), Brain & Behavior Research Foundation, Epix Pharmaceuticals (United States), Neuronetics (United States), Vanda Pharmaceuticals (United States), Imedex (United States), Wolters Kluwer (Netherlands), University of Michigan–Dearborn, Servier (France), Supernus Pharmaceuticals (United States), PureTech (United States), Cambridgeshire and Peterborough NHS Foundation Trust, Wolters Kluwer Health, Eisai (United States), National Institute of Mental Health, American Psychiatric Association, National Institute of Mental Health, Ganeden Biotech (United States), Covance (United Kingdom), Wyeth, Labopharm Inc. (Canada), ICON PLC (Ireland), FORUM Pharmaceuticals (United States), Orexigen Therapeutics (United States), American Society of Clinical Psychopharmacology, Belvoir Media Group (United States), Organon (Netherlands), Takeda (Japan), Covance (United States), Bayer (Germany), BioMarin (United States), Grünenthal Group (Germany)
ORCID: 0000-0002-5326-1306
Observed ORCID: 0000-0002-5326-1306
OpenAlex ID: A5000465215
